Brief: Sonoma Pharmaceuticals Expands Negative-Pressure Wound Therapy Products In US
April 9 (Reuters) - Sonoma Pharmaceuticals Inc SNOA.O :
* SONOMA PHARMACEUTICALS INC: ANNOUNCED EXPANSION OF ITS
MICROCYN®
NEGATIVE-PRESSURE WOUND THERAPY (NPWT) SOLUTION PRODUCTS IN
UNITED STATES
Further company coverage: SNOA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing